PMID: 4382727Feb 10, 1967

Evaluation of the cardiac effects of several beta adrenergic blocking agents

Annals of the New York Academy of Sciences
J R Blinks

Abstract

No abstract listed.

References

Jul 1, 1965·Journal of Applied Physiology·J R Blinks
Jun 1, 1961·British Journal of Pharmacology and Chemotherapy·E MUSCHOLL
Aug 1, 1964·Biochemical Pharmacology·G HERTTING
Sep 1, 1947·British Journal of Pharmacology and Chemotherapy·H O Schild

Citations

Apr 1, 1972·Teratology·O C Jaffee
Nov 1, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·W BrandtK Seibel
Nov 10, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·E CarlssonB Tångstrand
Nov 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·J Y Su, D A Malencik
Nov 1, 1967·European Journal of Pharmacology·L A Chahl, S R O'Donnell
Oct 1, 1969·European Journal of Pharmacology·J L WaleM J Rand
Sep 1, 1970·European Journal of Pharmacology·S R O'Donnell
Sep 1, 1970·European Journal of Pharmacology·M Bristow, R D Green
Jan 1, 1970·European Journal of Pharmacology·R A Gillis, K I Melville
Mar 1, 1970·European Journal of Pharmacology·J L Wale
Jul 1, 1971·European Journal of Pharmacology·J R BoissierS Larno
May 1, 1972·European Journal of Pharmacology·E OchoaE De Robertis
Jan 1, 1972·European Journal of Pharmacology·J J Parr, P R Urquilla
May 1, 1973·European Journal of Pharmacology·O D GulatiP R Raghunath
Apr 1, 1973·European Journal of Pharmacology·T Fenyvesi, P Hadházy
Feb 1, 1973·European Journal of Pharmacology·R K SrivastavaK P Bhargava
May 1, 1974·European Journal of Pharmacology·C K BucknerM O'Connor
Nov 1, 1975·European Journal of Pharmacology·B N SinghR M Whitlock
Jun 15, 1978·European Journal of Pharmacology·A M GrantS I Ankier
Jul 1, 1969·Progress in Cardiovascular Diseases·W C Elliott, J M Stone
Jan 1, 1976·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·R T BrittainD Jack
Jan 1, 1986·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·A L Pascoe, J A Reynoldson
Jul 7, 1994·The New England Journal of Medicine·S H Hohnloser, R L Woosley
Aug 1, 1977·British Journal of Clinical Pharmacology·D G McDevitt
May 1, 1970·British Journal of Pharmacology·B Levy, M Wasserman
Nov 1, 1970·British Journal of Pharmacology·A M Barrett, J Carter
Aug 1, 1971·British Journal of Pharmacology·E S Assem, H O Schild
Jan 1, 1971·British Journal of Pharmacology·J R Bassett
Aug 1, 1972·British Journal of Pharmacology·J B FarmerR J Marshall
May 1, 1972·British Journal of Pharmacology·K J Broadley
Jan 1, 1977·British Journal of Pharmacology·M E Conolly, J K Greenacre
May 1, 1995·British Journal of Pharmacology·S W Martin, K J Broadley
Feb 1, 1993·Journal of Cardiovascular Electrophysiology·R Ruffy
Jan 1, 1972·Acta Pharmacologica Et Toxicologica·H Refsum, K Landmark
Dec 30, 1971·Annals of the New York Academy of Sciences·A D CareH J Gitelman
Jan 1, 1970·The Journal of Pharmacy and Pharmacology·J B Farmer, R A Coleman
Apr 1, 1972·The Journal of Pharmacy and Pharmacology·T FenyvesiC T Dollery
Aug 1, 1972·British Heart Journal·I HuttonT D Lawrie
Apr 1, 1973·The Journal of Clinical Investigation·G BodemC A Chidsey
Jan 1, 1972·Archives internationales de physiologie et de biochimie·A R MattiazziE S Blesa
May 27, 2008·Pharmacology & Therapeutics·Alberto J Kaumann, Peter Molenaar
Feb 10, 1967·Annals of the New York Academy of Sciences·N C Moran
Aug 12, 1993·The American Journal of Cardiology·M J Antonaccio, A Gomoll
Nov 1, 1969·Metabolism: Clinical and Experimental·G Burke
Jan 2, 1990·The American Journal of Cardiology·M J Antonaccio, A Gomoll
Feb 1, 1969·The American Journal of Medicine·L WienerJ W Cox
Sep 1, 1968·The American Journal of Cardiology·G MarchettiV Noseda
Nov 1, 1968·The American Journal of Cardiology·J A NicoteroA P Shapiro
Aug 1, 1969·The American Journal of Cardiology·J H Vogel, C A Chidsey
Jun 1, 1972·British Journal of Pharmacology·W G Nayler
Jan 1, 1970·Circulation Research·C L SkeltonS E Epstein
May 14, 1971·Nature·H P Rang
Nov 1, 2001·Current Protocols in Pharmacology·N P ShankleyG F Watt
Mar 1, 1970·The Journal of Pharmacy and Pharmacology·G E Moore, S R O'Donnell
Sep 1, 1984·The Journal of Pharmacy and Pharmacology·B HughesJ R Parratt
Jan 1, 1982·British Journal of Clinical Pharmacology·B Hahn, B E Strauer
Apr 1, 1983·The American Journal of Physiology·M D Meglasson, R L Hazelwood

Related Concepts

Felis catus
Cocaine Hydrochloride
Ethanolamines
Cavia porcellus
Heart
Right Atrial Structure
Novodrin
Metoxamine Wellcome
Inotropism
Norepinephrine, (+, -)-Isomer

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

The Tendon Seed Network

Tendons are rich in the extracellular matrix and are abundant throughout the body providing essential roles including structure and mobility. The transcriptome of tendons is being compiled to understand the micro-anatomical functioning of tendons. Discover the latest research pertaining to the Tendon Seed Network here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Incretins

Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Long COVID-19

“Long Covid-19” describes illness in patients who are reporting long-lasting effects of the SARS-CoV-19 infection, often long after they have recovered from acute Covid-19. Ongoing health issues often reported include low exercise tolerance and breathing difficulties, chronic tiredness, and mental health problems such as post-traumatic stress disorder and depression. This feed follows the latest research into Long Covid.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.